Memorial Sloan Kettering Cancer Center - Commack is a clinical research site located in Commack, New York, United States 11725.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
Memorial Sloan Kettering Cancer Center - Commack has participated in 9 clinical trials with 4 currently active.
Therapeutic areas: Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV, Diffuse Large B-Cell Lymphoma.
Sponsors: EMD Serono Research & Development Institute, Inc., Hoffmann-La Roche, Taiho Oncology, Inc..
Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Memorial Sloan Kettering Cancer Center - Commack has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Memorial Sloan Kettering Cancer Center - Commack has 9 clinical trials on record, with 4 currently active. Their work covers Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV, Diffuse Large B-Cell Lymphoma.
Yes — Memorial Sloan Kettering Cancer Center - Commack holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.